As per
the CII and BGG report, an analysis of global medical
market growth shows that emerging markets will play a
critical role, accounting for more than half of the
growth over the next ten years. Besides being
important markets that cannot be ignored for global
companies, emerging markets are relevant innovation
and manufacturing hubs with the share of registrations
from emerging markets across Class I, Class II and
Class III devices having doubled over the last ten
years.
The
global market for medical polymers is expected to
reach US$7.05 billion by 2020, according to a study by
Grand View Research. |
accounting for nearly 50% of the global volume.
Medical packaging being the second largest application
is expected to witness the fastest growth over the
forecast period owing to substitution of conventional
materials such as glass by PVC, PP and engineering
thermoplastics.
Other
applications such as active implantable devices and
tissue engineering will show favourable growth over
the next few years, providing interesting
opportunities in the Medical Devices Industry.
Several
factors are leading to growth in this market. Perhaps
the most obvious is the ageing of the |
Engineering Polymers (EPs) have several advantages
over traditional materials, which can include weight,
biocompatibility, and cost. Concerns in 2012
surrounding the wear and corrosion of metal-on-metal (MoM)
hip implants have also led to a surge in the medical
community's uptake of implants containing EPs. One
reason why device manufacturers are looking for a
shift from traditional materials to EPs is that
high-performance engineering polymers —such as Poly
Ether Ether Ketone ( PEEK ) - are less expensive than
medical-grade metals such as titanium, have excellent
chemical, thermal, and mechanical stability and are
radiolucent, making implants compatible with a range
of medical-imaging tools. Devices made from
|
Medical
polymers represent a major opportunity in the medical
materials market over the next few years. Many Medical
Disposables Devices & Implants incorporate polymers,
either as key components or as coating to improve the
biocompatibility of other materials.
Modern
day healthcare would simply not be possible without
the use of plastics. Plastics are robust and durable,
and able to withstand frequent sterilisation, severe
temperatures and chemical environments. There are
ongoing developments in modified and biodegradable
polymers designed for use in a wide range of
applications, from implants to pharmaceutical
preparations and drug-delivery systems.
Medical
devices and equipment is the most dominant
|
application segment for medical polymers population in
developed nations is expanding the addressable market
for polymer implants. Many polymer implants are
specifically intended to assist elder patients.
Opportunity in this market has also expanded because
the latest technical developments in medical polymers
can fine tune implant capabilities, enable better fits
for implants, and increase biocompatibility. Polymer
structures can also now substitute for cartilage or
enable doctors to grow a patient's tissue for
transplants.
The new
legal protections that followed the silicone breast
implant debacle have considerably reduced the risk in
the medical polymer space. And as a result of all of
these factors, the medical polymer business has taken
off, with the emergence of new start-ups and plenty of
M&A activity. |
PEEK
show the lowest wear rate of any counter metallic
material.
Complementary manufacturing technologies - such as 3D
printing—extend their capabilities, enabling
custom-fit implants, which further help to drive
demand for EPs in health-care applications.
Countervailing forces include strict regulatory
guidelines and volatile raw material prices, which
have held back the medical polymers market.
This
issue highlights availability of wide range of Medical
Polymers in India along with emerging new
applications, technological developments, growth
pattern as well as effect of changing regulatory norms
as shared by leading national and international
providers. |